Table 4

Myc rearrangement and gain/amplification in pediatric DLBCL

Case IDPathologic diagnosisMolecular diagnosis by GEP
Age, ySext(8;14)8q24 CN
BL vs DLBCLDLBCL subgroup
P01 DLBCL DLBCL GCB − 3-4 
P02 DLBCL DLBCL GCB 10 − 3-5 
P03 DLBCL DLBCL GCB 13 − 3-4 
P04 DLBCL DLBCL GCB 18 − ND 
P05 DLBCL DLBCL PMBL 15 − 
P06 DLBCL DLBCL UC 11 − 
P07 DLBCL DLBCL UC 18 3-4 
P08 BL DLBCL ABC 
P09 BL DLBCL UC 11 
P10 BL DLBCL GCB ND 
P11 BL DLBCL GCB 
P12 BL DLBCL GCB 10 − 
P13 BL DLBCL GCB 10 − 3-4 
P14 BL DLBCL GCB − 
P15 BL DLBCL GCB − 
P16 BL DLBCL GCB ND Amplification 
P17 BL DLBCL GCB 12 − ND 
Case IDPathologic diagnosisMolecular diagnosis by GEP
Age, ySext(8;14)8q24 CN
BL vs DLBCLDLBCL subgroup
P01 DLBCL DLBCL GCB − 3-4 
P02 DLBCL DLBCL GCB 10 − 3-5 
P03 DLBCL DLBCL GCB 13 − 3-4 
P04 DLBCL DLBCL GCB 18 − ND 
P05 DLBCL DLBCL PMBL 15 − 
P06 DLBCL DLBCL UC 11 − 
P07 DLBCL DLBCL UC 18 3-4 
P08 BL DLBCL ABC 
P09 BL DLBCL UC 11 
P10 BL DLBCL GCB ND 
P11 BL DLBCL GCB 
P12 BL DLBCL GCB 10 − 
P13 BL DLBCL GCB 10 − 3-4 
P14 BL DLBCL GCB − 
P15 BL DLBCL GCB − 
P16 BL DLBCL GCB ND Amplification 
P17 BL DLBCL GCB 12 − ND 

The abnormal range for MYC rearrangement is 15%-100%. The abnormal range for MYC amplification is 10%-100%. The abnormal range for multiple copies of 8q24 is 10%-100%.

UC indicates unclassifiable DLBCL; and ND, not determined.

Close Modal

or Create an Account

Close Modal
Close Modal